High Bioactivity Recombinant Basic Fibroblast Growth Factor For
bFGF can improve the cell growth microenvironment and promote the
synthesis of deep elastic fibers and collagen, so as to restore the
skin with elasticity and make the skin slides tenderly. It can also
promote the growth and development of fibroblasts and constantly
replace the aging cells with new cells, so as to achieve the
anti-wrinkle and wrinkle removal effect. In addition, bFGF can not
only stimulate the formation and epithelialization of skin
granulation tissue, but also regulate collagen degradation and
renewal, thereby reducing wound healing time and reduce the scar
formation.It can be used as cosmetics to add raw materials.
- Model Number: HY201M1
- Purity: Greater than 95% as determined by SDS-PAGE.
- Source: Rice Grain (Oryza Sativa)
- Physical Appearance: White lyophilized powder
- Formulation: OsrbFGF is lyophilized with OsrHSA as the stabilizer.
- Endotoxin: Less than 1EU/ ug
- Biological Activity: The ED50 is ≤1ng/ml determined by a cell proliferation assay using
- Storage and Handling: Lyophilized OsrbFGF can remain stable at -20℃
for at least 12 months
|Product Name||Recombinant Basic Fibroblast Growth Factor|
|Source||Rice Grain (Oryza Sativa)|
|Physical Appearance||White lyophilized powder|
|Formulation||bFGF is lyophilized with mannitol as the stabilizer|
|Purity||Greater than 95% as determined by SDS-PAGE and HPLC analysis.|
|Endotoxin||Less than 1EU/ ug|
|Restrictions||FOR RESEARCH, LABORATORY AND MANUFACTURE USE ONLY. NOT INTENDED FOR
DIRECT USE ON HUMANS.|
1. Healthgen has a professional quality control department, in
which 50% of them have master's degree or higher. There are 14
employees in the quality department, 9 of them are in QA and 5 are
in QA. All of them have rich experience in analysis research or
quality inspection. Half of them have graduated diploma. Every year
there are more than 50 training courses, which cover GMP, SOP,
specification, hygiene, QA, QC issues, etc.
We strictly control the quality of our products to ensure that all
products into the market will be in line with quality standards.
Healthgen has a series of instruments, which are listed as below.
|Osmotic pressure detector||Tianjin SMC30C-1|
|Kjeldahl apparatus||Jinan K9840|
|Karl fischer moisture meter||Mettler Toledo|
|Atomic absorption instrument||PE|
2. Healthgen recombinant bFGF has excellent batch consistency.
Using self-pollination rice as the bioreactor to express the rbFGF,
with the world's advanced facility and top production proceeding to
extract and purify the rbFGF, Healthgen can ensure the excellent
consistency of rbFGF from different batches.
3. The rice endosperm specific expression platform is easy to be
large-scale. The rice endosperm has the protein body, which can
keeps proteins stability and bioactivity. At present, the
production capacity is almost 1 kg / year.
Healthgen Biotech, always pay great attention to the original
technological innovation and intellectual property protection, has
the titles of “Hubei Province Molecular Pharmaceutical Engineering
Research Center” and “Protein Purification Research Center”. The
rice endosperm cell high expression technology platform and other
core technology have applied and gained 13 domestic and
international patents; and won the “2012 Hubei Provincial Science
and technology invention Award”, “2013 National Science and
Technology Invention Award and China Patent Excellence Award’. The
project obtained the funding from the National Ministry of science
and high technology “863 plan”, Major national science and
technology plan “Major projects of new varieties of genetically
modified organisms” and “Major projects for new drug discovery”,
the National Development and Reform Commission “Pilot development
of strategic emerging industries”, National Ministry of science and
technology innovation fund and state and local plans for all kinds
of talented people funding. In July 2015, Healthgen Biotech became
a public company on the "China New OTCBB", a national share
transfer system for SMEs and officially known as the National
Equities Exchange and Quotations, which is the “first stock” of the
plant-derived pharmaceutical in China and even the world.